The long-term efficacy of lamivudine in chronic hepatitis B: interim analysis of 3-year's clinical course

Zhonghua nei ke za zhi [Chinese journal of internal medicine]

Volumn 42, Issue 6, 2003, Pages 382-387

  Yao, Guang bi ^a   Wang, Bao en ^a   Cui, Zhen yu ^a   Yao, Ji lu ^a   Zeng, Min de ^a  

^a Shanghai Jing An Qu Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; LAMIVUDINE; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIROLOGY; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DNA, VIRAL; DOUBLE-BLIND METHOD; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 7244222897     PISSN: 05781426     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)